I Peter

Summary

Affiliation: Mount Sinai School of Medicine
Country: USA

Publications

  1. pmc Association of type 2 diabetes susceptibility loci with one-year weight loss in the look AHEAD clinical trial
    Inga Peter
    Department of Genetics and Genomic Sciences, Mount Sinai School of Medicine, New York, NY, USA
    Obesity (Silver Spring) 20:1675-82. 2012
  2. pmc ANGPTL4 variants E40K and T266M are associated with lower fasting triglyceride levels in Non-Hispanic White Americans from the Look AHEAD Clinical Trial
    Melissa C Smart-Halajko
    Division of Cardiovascular Genetics, British Heart Foundation Laboratories, Department of Medicine, Royal Free and UCL Medical School, London, UK
    BMC Med Genet 12:89. 2011
  3. pmc Activation of p38 MAPK pathway in the skull abnormalities of Apert syndrome Fgfr2(+P253R) mice
    Yingli Wang
    Department of Genetics and Genomic Sciences, Mount Sinai School of Medicine, New York, New York, USA
    BMC Dev Biol 10:22. 2010
  4. pmc Association between arterial stiffness and variations in oestrogen-related genes
    I Peter
    Department of Genetics and Genomic Sciences, Mount Sinai School of Medicine of New York University, New York, NY 10029, USA
    J Hum Hypertens 23:636-44. 2009
  5. pmc Associations of APOE gene polymorphisms with bone mineral density and fracture risk: a meta-analysis
    I Peter
    Department of Genetics and Genomic Sciences, Mount Sinai School of Medicine, New York 10029, USA
    Osteoporos Int 22:1199-209. 2011
  6. pmc Evaluation of 22 genetic variants with Crohn's disease risk in the Ashkenazi Jewish population: a case-control study
    Inga Peter
    Department of Genetics and Genomic Sciences, Mount Sinai School of Medicine, New York, NY 10029 USA
    BMC Med Genet 12:63. 2011
  7. pmc Multi-ethnic distribution of clinically relevant CYP2C genotypes and haplotypes
    S Martis
    Department of Genetics and Genomic Sciences, Mount Sinai School of Medicine, New York, NY 10029, USA
    Pharmacogenomics J 13:369-77. 2013
  8. pmc Identification of CYP2C19*4B: pharmacogenetic implications for drug metabolism including clopidogrel responsiveness
    S A Scott
    Department of Genetics and Genomic Sciences, Mount Sinai School of Medicine, New York, NY 10029, USA
    Pharmacogenomics J 12:297-305. 2012

Collaborators

Detail Information

Publications8

  1. pmc Association of type 2 diabetes susceptibility loci with one-year weight loss in the look AHEAD clinical trial
    Inga Peter
    Department of Genetics and Genomic Sciences, Mount Sinai School of Medicine, New York, NY, USA
    Obesity (Silver Spring) 20:1675-82. 2012
    ....
  2. pmc ANGPTL4 variants E40K and T266M are associated with lower fasting triglyceride levels in Non-Hispanic White Americans from the Look AHEAD Clinical Trial
    Melissa C Smart-Halajko
    Division of Cardiovascular Genetics, British Heart Foundation Laboratories, Department of Medicine, Royal Free and UCL Medical School, London, UK
    BMC Med Genet 12:89. 2011
    ....
  3. pmc Activation of p38 MAPK pathway in the skull abnormalities of Apert syndrome Fgfr2(+P253R) mice
    Yingli Wang
    Department of Genetics and Genomic Sciences, Mount Sinai School of Medicine, New York, New York, USA
    BMC Dev Biol 10:22. 2010
    ..We previously reported an inbred transgenic mouse model with the Fgfr2 +/S252W mutation on the C57BL/6J background for Apert syndrome. Here we present a mouse model for the Fgfr2+/P253R mutation...
  4. pmc Association between arterial stiffness and variations in oestrogen-related genes
    I Peter
    Department of Genetics and Genomic Sciences, Mount Sinai School of Medicine of New York University, New York, NY 10029, USA
    J Hum Hypertens 23:636-44. 2009
    ..Our findings will need to be replicated in additional cohorts...
  5. pmc Associations of APOE gene polymorphisms with bone mineral density and fracture risk: a meta-analysis
    I Peter
    Department of Genetics and Genomic Sciences, Mount Sinai School of Medicine, New York 10029, USA
    Osteoporos Int 22:1199-209. 2011
    ..Despite lower trochanteric and lumbar BMD in APOE4 carriers, there is insufficient evidence to support a consistent association of APOE with bone health...
  6. pmc Evaluation of 22 genetic variants with Crohn's disease risk in the Ashkenazi Jewish population: a case-control study
    Inga Peter
    Department of Genetics and Genomic Sciences, Mount Sinai School of Medicine, New York, NY 10029 USA
    BMC Med Genet 12:63. 2011
    ..We evaluated a set of well-established CD-susceptibility variants to determine if they can explain the increased CD risk in the AJ population...
  7. pmc Multi-ethnic distribution of clinically relevant CYP2C genotypes and haplotypes
    S Martis
    Department of Genetics and Genomic Sciences, Mount Sinai School of Medicine, New York, NY 10029, USA
    Pharmacogenomics J 13:369-77. 2013
    ..These results have important implications for pharmacogenomic association studies involving the CYP2C locus and are clinically relevant when administering CYP2C-substrate medications. ..
  8. pmc Identification of CYP2C19*4B: pharmacogenetic implications for drug metabolism including clopidogrel responsiveness
    S A Scott
    Department of Genetics and Genomic Sciences, Mount Sinai School of Medicine, New York, NY 10029, USA
    Pharmacogenomics J 12:297-305. 2012
    ..Combining CYP2C19 and ABCB1 identified ∼1 in 3 AJ and ∼1 in 2 SJ individuals at increased risk for adverse responses to clopidogrel. These data underscore the importance of including *4B and *17 when clinically genotyping CYP2C19...